Erysipelas
Summary
Erysipelas is an acute, superficial bacterial skin infection involving the upper dermis and superficial lymphatics. It is almost always caused by Group A Streptococcus (Streptococcus pyogenes). The classic presentation is a well-demarcated, raised, bright red plaque with an advancing, sharply defined border. Unlike cellulitis, erysipelas is more superficial and has clear margins. The face and lower legs are the most common sites. Patients typically present with sudden-onset fever, rigors, and malaise. Treatment is with penicillin-based antibiotics. The prognosis is excellent with appropriate treatment.
Key Facts
- Organism: Group A Streptococcus (Strep pyogenes) - 80%+
- Depth: Upper dermis and superficial lymphatics (superficial)
- Classic Sign: Well-demarcated, raised, bright red plaque
- Site: Face (20%), Lower leg (70%)
- Treatment: Penicillin V (oral) or Benzylpenicillin (IV if severe)
- Prognosis: Excellent with treatment; recurrence common (30%)
Clinical Pearls
"Sharp Edges = Erysipelas, Blurry Edges = Cellulitis": Erysipelas has well-demarcated, raised borders. Cellulitis has indistinct, merging edges. This is the key clinical distinction.
"Fever Comes First": Patients often have rigors and high fever BEFORE the rash appears. This can cause diagnostic confusion.
"The Malar Butterfly": Classic facial erysipelas spares the nasolabial folds and mimics a butterfly pattern, similar to lupus rash - but erysipelas is hot, tender, and the patient is unwell.
"Recurrence is Common": 30% get recurrent erysipelas. Identify and treat predisposing factors (lymphoedema, tinea pedis, venous insufficiency).
Incidence
- 10-100 per 100,000 per year
- Higher in elderly and immunocompromised
Demographics
- Bimodal age distribution: Young children and elderly (>60)
- Equal M:F (slight female predominance in some studies)
Risk Factors
| Factor | Mechanism |
|---|---|
| Lymphoedema | Impaired lymphatic drainage |
| Venous insufficiency | Stasis, oedema |
| Tinea pedis (athlete's foot) | Entry point for bacteria |
| Leg ulcers | Skin breach |
| Previous erysipelas | Damaged lymphatics |
| Obesity | Skin folds, lymphoedema |
| Immunosuppression | Diabetes, HIV, chemotherapy |
| Injection drug use | Skin breaks |
Sites
- Lower legs: 70%
- Face: 20%
- Arms: 5%
- Other: 5%
Aetiology
| Organism | Frequency |
|---|---|
| Group A Streptococcus | 80%+ |
| Group G/C Streptococcus | 10% |
| Staphylococcus aureus | Rare (more often in cellulitis) |
Mechanism
- Entry point: Skin break (tinea pedis, trauma, ulcer, eczema)
- Bacterial invasion: Streptococci enter upper dermis
- Superficial spread: Rapid horizontal spread through lymphatics
- Inflammatory response: Intense local inflammation, cytokine release
- Clinical features: Well-demarcated erythema with raised edge
Erysipelas vs Cellulitis
| Feature | Erysipelas | Cellulitis |
|---|---|---|
| Depth | Upper dermis, superficial | Deeper dermis and subcutaneous |
| Organism | Group A Strep (usually) | Staph aureus or Strep |
| Border | Well-demarcated, raised | Indistinct, merging |
| Systemic symptoms | More prominent, rapid onset | Less prominent |
| Surface | "Peau d'orange", shiny | May be duller |
Prodrome
Symptoms
| Feature | Description |
|---|---|
| Rash | Bright red, hot, tender, rapidly expanding |
| Borders | Well-demarcated, raised (palpable edge) |
| Surface | Shiny, tense, "peau d'orange" texture |
| Fever | Often high (>8.5°C), with rigors |
| Pain | Marked local tenderness |
Sites
Face (Malar):
Lower Leg:
Complications Signs
Vital Signs
- Fever (often >38°C)
- Tachycardia
- May be hypotensive if septic
Inspection
- Bright red, shiny plaque
- Well-demarcated, raised edge
- "Peau d'orange" texture (skin pitting)
- Bullae in severe cases
Palpation
- Warm to touch
- Tender
- Palpable raised edge demarcates from normal skin
Differentiation from Cellulitis
| Finding | Erysipelas | Cellulitis |
|---|---|---|
| Edge | Palpable, raised, sharp | Indistinct |
| Surface | Shiny, tense | Less shiny |
| Systemic symptoms | More marked | Less marked |
Look for Entry Point
- Tinea pedis (between toes)
- Leg ulcer
- Trauma/abrasions
- Eczema
Clinical Diagnosis
- Usually clinical
- Blood tests support severity assessment
Blood Tests
| Test | Purpose |
|---|---|
| FBC | Raised WCC (neutrophilia) |
| CRP | Elevated; monitors response |
| Blood cultures | If septic (positive in only 5%) |
| U&E | Assess renal function, hydration |
| Glucose | Screen for diabetes |
Imaging
- Usually not required
- Ultrasound/MRI if concern for deep abscess or necrotizing fasciitis
Microbiology
- Skin swabs rarely helpful (low yield)
- Serology (ASOT): Retrospective diagnosis
Initial Assessment
┌──────────────────────────────────────────────────────────┐
│ ERYSIPELAS MANAGEMENT │
├──────────────────────────────────────────────────────────┤
│ │
│ ASSESS SEVERITY (Eron Classification): │
│ │
│ CLASS I (Mild): │
│ • No systemic toxicity │
│ • No comorbidities │
│ → ORAL antibiotics, outpatient │
│ │
│ CLASS II (Moderate): │
│ • Systemically unwell (fever, tachycardia) OR │
│ • Has comorbidities (diabetes, PVD) │
│ → May need initial IV, then step down │
│ │
│ CLASS III (Severe): │
│ • Significant systemic upset/sepsis or │
│ • Limb-threatening │
│ → IV antibiotics, admission │
│ │
│ CLASS IV (Sepsis/NSTI): │
│ • Sepsis syndrome OR │
│ • Necrotizing fasciitis suspected │
│ → Urgent IV + surgical review │
│ │
└──────────────────────────────────────────────────────────┘
Antibiotic Treatment
| Severity | Antibiotic | Duration |
|---|---|---|
| Mild (oral) | Phenoxymethylpenicillin (Penicillin V) 500mg QDS | 7-14 days |
| Alternative (allergy) | Clarithromycin 500mg BD | 7-14 days |
| Moderate/Severe (IV) | Benzylpenicillin 1.2g QDS | Step down when improving |
| Severe/septic | Benzylpenicillin + Flucloxacillin | As per microbiologist |
Supportive Care
- Elevate affected limb (reduces oedema)
- Mark edge with skin marker (monitor spread)
- Analgesia (paracetamol, ibuprofen)
- Hydration
- Treat entry point (e.g., tinea pedis)
Follow-Up
- Review at 48-72 hours
- Assess response (reducing erythema, fever settling)
- Identify predisposing factors for recurrence prevention
Acute
- Abscess formation
- Sepsis
- Deep vein thrombosis (immobility)
- Necrotizing fasciitis (rare but serious)
Chronic
- Recurrent erysipelas (30%)
- Lymphoedema (damaged lymphatics)
- Post-inflammatory hyperpigmentation
With Treatment
- Excellent prognosis
- Most improve within 48-72 hours
- Full resolution within 1-2 weeks
Recurrence
- 30% recurrence rate
- Prevention: Treat underlying factors, prophylactic antibiotics if recurrent
Prophylaxis for Recurrent Erysipelas
- Penicillin V 250mg BD long-term (or Erythromycin if allergic)
- Reduces recurrence by 50%
Key Guidelines
- NICE CKS: Cellulitis and Erysipelas
- CREST Guidelines: Management of Cellulitis
- British Dermatology Guidelines
Key Evidence
Antibiotics
- Penicillin remains first-line (Group A Strep sensitivity)
- No proven benefit of anti-staphylococcal agents in typical erysipelas
Prophylaxis
- RCTs show long-term penicillin reduces recurrence by ~50%
What is Erysipelas?
Erysipelas is a skin infection caused by bacteria, usually streptococcus ("strep"). It causes a bright red, hot, swollen area on the skin with a clearly defined edge. It most commonly affects the face or lower legs.
What Causes It?
Bacteria enter through a break in the skin, such as:
- Athlete's foot (cracked skin between toes)
- Cuts or grazes
- Leg ulcers
- Eczema
What Are the Symptoms?
- Sudden onset of fever, chills, and feeling unwell
- A bright red, painful, swollen area of skin
- The edge of the redness is clearly defined and raised
- The affected area feels hot
How is it Treated?
Antibiotics are very effective. Most people get oral antibiotics to take at home. If you're very unwell, you may need antibiotics through a drip in hospital.
You should also:
- Rest with the affected limb raised
- Take paracetamol for pain and fever
- Drink plenty of fluids
How Long Does it Take to Get Better?
You should start to feel better within 2-3 days. The redness may take 1-2 weeks to completely disappear.
Can it Come Back?
Yes, about 1 in 3 people get erysipelas again, especially if there's an underlying problem like lymphoedema or athlete's foot. Treating these conditions helps prevent recurrence.
Primary Guidelines
- NICE Clinical Knowledge Summaries. Cellulitis and Erysipelas. cks.nice.org.uk
- CREST Guidelines. Guidelines on the Management of Cellulitis in Adults. 2005.
Key Studies
- Sjöblom AC, et al. Antibiotic prophylaxis in recurrent erysipelas. Infection. 1993;21(6):390-393. PMID: 8132368
- Morris AD. Cellulitis and erysipelas. BMJ Clin Evid. 2008. PMID: 19450314